DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 202155
» See Plans and Pricing
The generic ingredient in ELIQUIS is apixaban. There are thirty drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the apixaban profile page.
Summary for 202155
Tradename: | ELIQUIS |
Applicant: | Bristol Myers Squibb |
Ingredient: | apixaban |
Patents: | 2 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 202155
Mechanism of Action | Factor Xa Inhibitors |
Suppliers and Packaging for NDA: 202155
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ELIQUIS | apixaban | TABLET;ORAL | 202155 | NDA | E.R. Squibb & Sons, L.L.C. | 0003-0893 | 0003-0893-21 | 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0003-0893-21) |
ELIQUIS | apixaban | TABLET;ORAL | 202155 | NDA | E.R. Squibb & Sons, L.L.C. | 0003-0893 | 0003-0893-31 | 10 BLISTER PACK in 1 CARTON (0003-0893-31) > 10 TABLET, FILM COATED in 1 BLISTER PACK |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 2.5MG | ||||
Approval Date: | Dec 28, 2012 | TE: | AB | RLD: | Yes | ||||
Patent: | Start Trial | Patent Expiration: | Nov 21, 2026 | Product Flag? | Y | Substance Flag? | Y | Delist Request? | |
Patented Use: | PROPHYLAXIS OF DEEP VEIN THROMBOSIS (DVT) | ||||||||
Patent: | Start Trial | Patent Expiration: | Nov 21, 2026 | Product Flag? | Y | Substance Flag? | Y | Delist Request? | |
Patented Use: | PROPHYLAXIS OF DEEP VEIN THROMBOSIS AND PULMONARY EMBOLISM | ||||||||
Patent: | Start Trial | Patent Expiration: | Nov 21, 2026 | Product Flag? | Y | Substance Flag? | Y | Delist Request? | |
Patented Use: | PROPHYLAXIS OF PULMONARY EMBOLISM |
Expired US Patents for NDA 202155
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bristol Myers Squibb | ELIQUIS | apixaban | TABLET;ORAL | 202155-002 | Dec 28, 2012 | Start Trial | Start Trial |
Bristol Myers Squibb | ELIQUIS | apixaban | TABLET;ORAL | 202155-001 | Dec 28, 2012 | Start Trial | Start Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription